EMIS Group trading as expected in year-to-date
Healthcare software and systems provider EMIS Group said in an update on Thursday that trading for the year to date was in line with its expectations.
The AIM-traded firm, which was holding its annual general meeting later in the day, said it was maintaining its “leading positions” in specialist markets.
It said it was also benefiting from high levels of recurring revenue and remained in a “strong” financial position, with a robust pipeline of potential new business, investment and acquisition opportunities for 2022 and beyond.
The two acquisitions completed in the year so far, of Edenbridge and FourteenFish, were said to be performing well, with their integration progressing to plan and new market opportunities emerging as expected.
EMIS said it was investing in its technology and “cloud refresh” strategy, as well as in improved internal systems.
Those projects were expected to drive greater efficiencies in the coming years.
“The board is pleased to report a good start to trading in 2022 and believes the group continues to be very well placed to deliver greater insight, efficiency and integration in healthcare for the benefit of our customers across the NHS and private sectors,” said chief executive officer Andy Thorburn.
At 1108 BST, shares in EMIS Group were up 1.95% at 1,356p.